Search research articles
Contact Us
Filters
Showing results (491-500 of 512) with videos related to
Page
of 52
Sort By:
ESMO Open
|
April 30, 2021
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054]
C De Angelis, D Bruzzese, A Bernardo, et al.
Journal of Craniovertebral Junction & Spine
|
April 7, 2022
The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
Gregory R Toci, Jose A Canseco, Brian A Karamian, et al.
Emerging Infectious Diseases
|
April 8, 2011
Vaccinia virus infections in martial arts gym, Maryland, USA, 2008
Christine M Hughes, David Blythe, Yu Li, et al.
Oncogene
|
April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity
N Li, K Lee, Y Xi, et al.
Clinical Science (London, England : 1979)
|
September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
ESMO Open
|
April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
F Schettini, B Conte, G Buono, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
December 9, 2021
Family Pediatrician and Public Health collaboration, an alliance to increase vaccination coverage: an experience with MenB vaccination in Italy
A D'Avino, G Aloi, G Argo, et al.
Clinical Genetics
|
December 17, 2015
Expanding the clinical spectrum of the 'HDAC8-phenotype' - implications for molecular diagnostics, counseling and risk prediction
I Parenti, C Gervasini, J Pozojevic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 20, 2026
Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial
M Dugo, C-S Huang, D Egle, et al.
Frontiers in Pharmacology
|
April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
A Iurlo, D Cattaneo, D Consonni, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 512) with videos related to
Sort By:
Page
of 52
ESMO Open
|
April 30, 2021
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054]
C De Angelis, D Bruzzese, A Bernardo, et al.
Journal of Craniovertebral Junction & Spine
|
April 7, 2022
The impact of preoperative neurological symptom severity on postoperative outcomes in cervical spondylotic myelopathy
Gregory R Toci, Jose A Canseco, Brian A Karamian, et al.
Emerging Infectious Diseases
|
April 8, 2011
Vaccinia virus infections in martial arts gym, Maryland, USA, 2008
Christine M Hughes, David Blythe, Yu Li, et al.
Oncogene
|
April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity
N Li, K Lee, Y Xi, et al.
Clinical Science (London, England : 1979)
|
September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
ESMO Open
|
April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
F Schettini, B Conte, G Buono, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita
|
December 9, 2021
Family Pediatrician and Public Health collaboration, an alliance to increase vaccination coverage: an experience with MenB vaccination in Italy
A D'Avino, G Aloi, G Argo, et al.
Clinical Genetics
|
December 17, 2015
Expanding the clinical spectrum of the 'HDAC8-phenotype' - implications for molecular diagnostics, counseling and risk prediction
I Parenti, C Gervasini, J Pozojevic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 20, 2026
Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial
M Dugo, C-S Huang, D Egle, et al.
Frontiers in Pharmacology
|
April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
A Iurlo, D Cattaneo, D Consonni, et al.
Page
of 52